Journal Description
Clinical and Translational Neuroscience
Clinical and Translational Neuroscience
is an international, peer-reviewed, open access journal on neuroscience. The journal is owned by the Swiss Federation of Clinical Neuro-Societies and is published quarterly online by MDPI (from Volume 5 Issue 2-2021).
- Open Access— free for readers, with article processing charges (APC) paid by authors or their institutions.
- High Visibility: indexed within ESCI (Web of Science), Scopus, EBSCO, and other databases.
- Rapid Publication: manuscripts are peer-reviewed and a first decision is provided to authors approximately 33.9 days after submission; acceptance to publication is undertaken in 5.4 days (median values for papers published in this journal in the second half of 2024).
- Recognition of Reviewers: APC discount vouchers, optional signed peer review, and reviewer names published annually in the journal.
- Journal Cluster of Neurosciences: Brain Sciences, Neurology International, NeuroSci, Clinical and Translational Neuroscience, Neuroglia, Psychiatry International, Clocks & Sleep and Journal of Dementia and Alzheimer's Disease.
Impact Factor:
1.1 (2024)
Latest Articles
Clinical and Experiential Outcomes of Photobiomodulation Therapy as a Treatment for Fibromyalgia: A Scoping Review in Response to NICE Recommendations
Clin. Transl. Neurosci. 2025, 9(3), 29; https://doi.org/10.3390/ctn9030029 - 20 Jun 2025
Abstract
►
Show Figures
(1) Background: There has been a recent growth in evidence regarding the use, value and impact of photobiomodulation therapy for individuals with fibromyalgia. However, the nature of the evidence has, to the best of the authors’ knowledge, not been presented within a
[...] Read more.
(1) Background: There has been a recent growth in evidence regarding the use, value and impact of photobiomodulation therapy for individuals with fibromyalgia. However, the nature of the evidence has, to the best of the authors’ knowledge, not been presented within a scoping review. The objective of this work is to reveal the nature of the evidence, gaps in the evidence, and a map of the evidence considering photobiomodulation therapy against established policy guidelines; (2) Methods: A scoping review was undertaken considering all academic research that has examined the experiences and impact of photobiomodulation therapy on individuals with fibromyalgia; (3) Results: Our results highlight that, indeed, there is plentiful data available to address a high proportion of the concerns portrayed by the National Institute for Healthcare and Excellence. Outcome measures are wide-ranging, albeit demonstrating heterogeneity, and the results are extremely promising; (4) Conclusion: Based on the current evidence, the United Kingdom’s ‘standard of care’ for fibromyalgia needs to be ascertained, and stringent cost-effectiveness data needs to be collected and presented to governing bodies with the aim of integrating recommendations into future healthcare guidelines.
Full article
Open AccessArticle
Attention Test as a Predictive Marker of Vasospasm in Patients with Aneurysmal Subarachnoid Hemorrhage
by
Helaina Lehrer, Ankit Bansal, Nicki Mohammadi, Anmol Mittal, John Liang and Alexandra S. Reynolds
Clin. Transl. Neurosci. 2025, 9(2), 28; https://doi.org/10.3390/ctn9020028 - 18 Jun 2025
Abstract
Aneurysmal subarachnoid hemorrhage (aSAH) has high morbidity and mortality in part due to vasospasm and delayed cerebral ischemia (DCI). This retrospective, single-center, case–control study evaluates the accuracy of an attention test, counting backwards from twenty to one (TTO), for detecting vasospasm and DCI
[...] Read more.
Aneurysmal subarachnoid hemorrhage (aSAH) has high morbidity and mortality in part due to vasospasm and delayed cerebral ischemia (DCI). This retrospective, single-center, case–control study evaluates the accuracy of an attention test, counting backwards from twenty to one (TTO), for detecting vasospasm and DCI in patients admitted to the ICU with aSAH over one year. The odds of symptomatic vasospasm and hospital outcomes were compared between the inattention and control groups. A subgroup analysis included accuracy tests comparing TTO to radiographic vasospasm. Of 44 subjects, 24 had inattention during their ICU course. Compared to controls, the inattention group had increased odds of vasospasm (OR 72 [7.6–677.7], p = 0.001), with significantly longer ICU (5.9 days) and hospital (6.6 days) lengths of stay, and higher odds of discharge to other healthcare facilities (OR 11.4 [2.8 to 46.8], p < 0.001). Errors on TTO testing had a specificity and sensitivity of 78%, and a positive predictive value (PPV) of 91%, for radiographic vasospasm, primarily in the anterior circulation. This study provides support for future prospective research to help elucidate the utility of TTO testing for monitoring and treatment of patients with aSAH.
Full article
(This article belongs to the Topic Neurological Updates in Neurocritical Care)
►▼
Show Figures

Figure 1

Figure 1
Open AccessArticle
Effectiveness of a Multidisciplinary Headache Management Program: An Open-Label Pilot Study
by
Rini Souren, Balz Ronald Winteler, Nina Bischoff, Oliver Fluri, Johannes Grolimund, Adrian Scutelnic, Konrad Streitberger, David Beckwée and Christoph J. Schankin
Clin. Transl. Neurosci. 2025, 9(2), 27; https://doi.org/10.3390/ctn9020027 - 18 Jun 2025
Abstract
Migraine is a common disabling primary headache disorder with significant personal and socio-economic impacts. A combination of medication and non-pharmacological therapies is essential for migraine management. Outpatient multidisciplinary headache therapy has not yet been evaluated in Switzerland. This study evaluates the effectiveness of
[...] Read more.
Migraine is a common disabling primary headache disorder with significant personal and socio-economic impacts. A combination of medication and non-pharmacological therapies is essential for migraine management. Outpatient multidisciplinary headache therapy has not yet been evaluated in Switzerland. This study evaluates the effectiveness of the headache management program at Inselspital, Bern University Hospital, in improving headache-related disability in migraine patients. This open-label pilot study used prospectively assessed routine data from our headache registry. Participants aged 18 years or older with a diagnosis of migraine, confirmed by a headache specialist, were included. The program consisted of seven weekly sessions, each with a 50 min educational lecture and a 30 min progressive muscle relaxation (PMR) exercise. Primary outcomes were headache-related impact and disability, measured by the Headache Impact Test 6 (HIT-6) and Migraine Disability Assessment (MIDAS). Secondary outcomes included symptoms of anxiety, measured by the Generalized Anxiety Disorder 7-item scale (GAD-7), and symptoms of depression, assessed using the eight-item Patient Health Questionnaire depression scale (PHQ-8). Data were analysed using paired t-test and Wilcoxon signed rank tests. Significant improvements were observed in HIT-6 scores (pre-program: 65.2; post-program: 61.9; p = 0.012) and MIDAS scores (pre-program: 38; post-program: 27; p = 0.011), while PHQ-8 also showed a statistically significant reduction. Although the GAD-7 scores improved numerically, this change was not statistically significant. These findings suggest that the headache management program may reduce headache burden and disability; however, further research with larger samples is needed to confirm these preliminary results.
Full article
(This article belongs to the Section Headache)
►▼
Show Figures

Figure 1

Figure 1
Open AccessReview
Predictive Performance of Machine Learning with Evoked Potentials for SCI and MS Prognosis: A Meta-Analysis
by
Constantinos Koutsojannis and Dionysia Chrysanthakopoulou
Clin. Transl. Neurosci. 2025, 9(2), 26; https://doi.org/10.3390/ctn9020026 - 11 Jun 2025
Abstract
►▼
Show Figures
Evoked potentials (EPs), including somatosensory evoked potentials (SSEPs) and motor evoked potentials (MEPs), are used to assess neural conduction in spinal cord injury (SCI) and multiple sclerosis (MS), conditions marked by demyelination, inflammation, and axonal damage. Machine learning (ML), using data-driven algorithms, enhances
[...] Read more.
Evoked potentials (EPs), including somatosensory evoked potentials (SSEPs) and motor evoked potentials (MEPs), are used to assess neural conduction in spinal cord injury (SCI) and multiple sclerosis (MS), conditions marked by demyelination, inflammation, and axonal damage. Machine learning (ML), using data-driven algorithms, enhances EPs’ prognostic utility, but evidence synthesis is limited. This meta-analysis evaluated the predictive performance of EP-based ML models for SCI recovery (ASIA scale) and MS progression (EDSS) using a random-effects model. Five studies (n = 583) were included, extracting accuracy and area under the curve (AUC). Pooled results showed high predictive accuracy of 77.7% (95% CI, 75.1–80.3%; I² = 57%) and AUC 0.82 (95% CI, 0.79–0.85; I² = 55%). Stratified analyses by disease type (SCI vs. MS) or injury severity were not feasible due to the limited number of studies (n = 5). Sensitivity analysis excluding a rat model (N = 551) showed stable results (accuracy 76.9%; AUC 0.81). SSEP latency and MEP time series were key predictors, with amplitude critical in SCI and multimodal approaches enhancing performance. Moderate heterogeneity (I² = 55–57%) and limited studies constrain generalizability. This meta-analysis highlights EPs’ prognostic potential in ML-driven precision neurology, advocating for further human studies to validate multimodal approaches.
Full article

Figure 1

Figure 1
Open AccessPerspective
Post COVID-19 Conditions and Neurocognitive Impairment—Current Findings and Clinical Implications
by
Tarek Jebrini, Michael Ruzicka, Hans Stubbe and Kristina Adorjan
Clin. Transl. Neurosci. 2025, 9(2), 25; https://doi.org/10.3390/ctn9020025 - 22 May 2025
Abstract
Despite the increasing evidence of neurocognitive impairment (NCI) in patients suffering from post-COVID-19 conditions (PCC), the interplay between patient-reported symptoms and objective findings remains poorly characterized. Valid diagnostic tests and sufficient treatment strategies are lacking. We conducted a narrative perspective synthesis of current
[...] Read more.
Despite the increasing evidence of neurocognitive impairment (NCI) in patients suffering from post-COVID-19 conditions (PCC), the interplay between patient-reported symptoms and objective findings remains poorly characterized. Valid diagnostic tests and sufficient treatment strategies are lacking. We conducted a narrative perspective synthesis of current findings of NCI, standardized assessments (e.g., MoCA, PCCIS), and their association with inflammatory parameters. We highlighted findings on the discrepancy of subjective versus objectively measured neurocognitive impairment. The “subjectivity-objectivity-gap” may contribute to patient stigmatization, impair therapy adherence and be associated with a suboptimal clinical outcome. Although established multimodal interventions, such as cognitive rehabilitation, psychoeducation, group therapy, and pharmacotherapy—show preliminary efficacy, adherence may be compromised when subjective experiences of NCI are invalidated. We summarized the current state of the literature regarding demographic and clinical risk factors such as advanced age, lower education, neuropsychiatric comorbidities and evidence on the possible underlying role of persistent neuroinflammation in NCI in PCC. This perspective emphasizes the need for evidence-based diagnostic algorithms that integrate both subjective and objective NCI, explicitly addressing the risk of stigmatization. Future research should focus on addressing the neurobiological basis of NCI, discrepant NCI findings and associated stigmatization, and incorporate these findings in clinical guidelines.
Full article
(This article belongs to the Special Issue Brain Health)
Open AccessArticle
Associations Between P300 Latency and Reaction Time on Event-Related Potentials in Children with Varying Levels of Fluid Intelligence
by
Nikolaos C. Zygouris, Irini Dermitzaki, Panayiotis Patrikelis, Lambros Messinis and Eugenia I. Toki
Clin. Transl. Neurosci. 2025, 9(2), 24; https://doi.org/10.3390/ctn9020024 - 13 May 2025
Abstract
►▼
Show Figures
Exploring cognitive abilities is necessary in educational contexts, where such insights shape decisions about student placement and teaching methods. Traditionally, educational assessments have been leaned on academic performance to guide decisions related to grading and student placement. This study examines the relationships among
[...] Read more.
Exploring cognitive abilities is necessary in educational contexts, where such insights shape decisions about student placement and teaching methods. Traditionally, educational assessments have been leaned on academic performance to guide decisions related to grading and student placement. This study examines the relationships among specific neuropsychological measures, namely the Event Related Potentials (ERPs), P300 waveform, reaction time, and fluid intelligence in children. Raven’s Standard Progressive Matrices (RSPM) was utilized to assess intelligence levels. Based on their RSPM scores, participants were grouped into two categories: those with “high mental abilities” and those with “average mental abilities”. It was hypothesized that children with higher RSPM scores might display reduced P300 latencies and quicker reaction times, potentially reflecting greater neural efficiency. Electrophysiological data collected using ERPs, focusing on the P300 component. The results suggest a possible association between higher intelligence scores and shorter P300 latencies and quicker reaction times, which could support the concept of neural efficiency and the significance of cognitive speed in understanding intelligence. This investigation into the neuropsychological foundations of cognitive ability in children is in the same line with studies supporting how brain activity, connectivity, and processing efficiency vary. These differences could help develop educational strategies that are more tailored to individual cognitive processing styles.
Full article

Figure 1
Open AccessArticle
The Relationship Between Social Media Addiction and Sleepiness in Adolescents: A Cross-Sectional Study
by
Melike Y. Celik and Selver Güler
Clin. Transl. Neurosci. 2025, 9(2), 23; https://doi.org/10.3390/ctn9020023 - 11 Apr 2025
Abstract
Background/Objectives: Social media addiction has increased among adolescents, and this addiction has negatively affected their health. It is necessary to investigate how this addiction brings negative effects to adolescents. This study aimed to examine the relationship between social media addiction and sleepiness in
[...] Read more.
Background/Objectives: Social media addiction has increased among adolescents, and this addiction has negatively affected their health. It is necessary to investigate how this addiction brings negative effects to adolescents. This study aimed to examine the relationship between social media addiction and sleepiness in adolescents. Methods: Personal information form, Social Media Addiction Scale for Adolescents (SMAS), and Cleveland Adolescent Sleepiness Questionnaire (CASQ) were used as data collection tools. Prerequisites (correlation, linearity, continuous variable, normal distribution) for regression analysis were tested. The study sample consisted of adolescents between the ages of 10–18. The data were analyzed in the SPSS program. Results: It was determined that 37.9% of the adolescents had sleep problems. The increase in the use of social media significantly affects sleepiness rates (r = 0.61, p < 0.05). The increase in social media use can explain 37.5% of the increase in sleepiness rates (R2 = 0.375). It was observed that a 1-unit increase in social media use would increase the sleepiness rate by 0.79 (B = 0.79). Conclusions: A significant relationship was found between adolescents’ social media addiction and sleepiness. Social media addiction was seen as a predictor of sleepiness in adolescents.
Full article
Open AccessArticle
Sex and Gender Disparities in Missed Acute Ischemic Stroke: A Nested Case-Control Study
by
Cécile Barras, Michael Amiguet, Joëlle Schwarz, Patrik Michel and Carole Clair
Clin. Transl. Neurosci. 2025, 9(2), 22; https://doi.org/10.3390/ctn9020022 - 2 Apr 2025
Abstract
Backround: The aim is to analyze whether sex and gender are associated with missed acute ischemic stroke (M-AIS). Methods: We performed a nested case-control study, using data collected from March 2003 to December 2020 from ASTRAL (Acute STroke Registry and Analysis of Lausanne).
[...] Read more.
Backround: The aim is to analyze whether sex and gender are associated with missed acute ischemic stroke (M-AIS). Methods: We performed a nested case-control study, using data collected from March 2003 to December 2020 from ASTRAL (Acute STroke Registry and Analysis of Lausanne). M-AIS were compared with a randomly selected control sample of acute ischmemic stroke (AIS). We extracted six gender-related socioeconomic variables. A gendered socioeconomic position (SEP) score was constructed reflecting the level of correspondence with feminine characteristics. Associations between M-AIS and the gender-related socioeconomic variables and the gendered SEP score were investigated using logistic regression. Results: Of the 6007 AIS, 182 (3%) were M-AIS. 80 (44%) were women. No association between administrative sex and M-AIS was found (OR 1.25, 95% CI 0.78–2.00). Differences were found for gender-related socioeconomic variables, women in the middle professional category had higher odds of an M-AIS compared to women in the lower professional category (OR 3.93, 95% CI 1.19–13.03). Men with higher education had lower odds of an M-AIS compared to men with lower education (OR 0.31, 95% CI 0.10–0.92). For women, a 20-unit increase in the gendered SEP score was associated with lower odds of an M-AIS (OR 0.66, 95% CI 0.46–0.94). For men, the same increase in the score tended to higher the odds of an M-AIS (OR 1.52, 95% CI 1.00–2.32). Conclusions: The interaction of administrative sex with gender-related socioeconomic variables revealed different associations with M-AIS for women and men. Correspondence to expected gender norms may have a protective effect against M-AIS.
Full article
(This article belongs to the Special Issue Brain Health)
►▼
Show Figures

Figure 1

Figure 1
Open AccessArticle
Combining ROC Curves to Improve Diagnostic Values for Vitamin D3 and Chloride Co-Transporters in Connection to Epilepsy and Sleep Problems, Comorbidities in Autism Spectrum Disorders
by
Afaf El-Ansary, Altaf Alabdali, Abir Ben Bacha, Mona Alonazi and Laila Y. Al-Ayadhi
Clin. Transl. Neurosci. 2025, 9(2), 21; https://doi.org/10.3390/ctn9020021 - 1 Apr 2025
Abstract
►▼
Show Figures
Background: Autism spectrum disorders (ASDs) comprise a neurodevelopmental disease marked by impaired social communication and repetitive activities. An imbalance between excitatory and inhibitory neurotransmitters, such as glutamate and GABA, may play a significant function in ASDs. The neurophysiological process behind epilepsy is abnormal
[...] Read more.
Background: Autism spectrum disorders (ASDs) comprise a neurodevelopmental disease marked by impaired social communication and repetitive activities. An imbalance between excitatory and inhibitory neurotransmitters, such as glutamate and GABA, may play a significant function in ASDs. The neurophysiological process behind epilepsy is abnormal neuronal excitatory firing in particular brain regions brought on by a lack of GABAergic inhibition. The study of GABAergic dysfunction could explain the substantial comorbidity with epilepsy or increased susceptibility to seizures observed in people with autism. Objective: This study analyzes molecular indicators directly and indirectly related to GABAergic inhibitory signaling in individuals with autism and healthy controls, with the purpose of uncovering probable diagnoses. Methods: The study included 46 male autistic participants and 26 age- and gender-matched healthy controls. Plasma levels of two chloride co-transporters (KCC2, NKCC1), and vitamin D3 were evaluated using ELISA. Results: Autistic individuals showed a significant drop in all three examined variables when compared to healthy controls. Statistical methods such as correlation, combined receiver operating characteristic (ROC) curve analysis, and multiple regression modeling were used to assess the diagnostic value and interrelationships of these biomarkers. A significant increase in the area under the curve was seen using the combined ROC curve analysis. The combined variables also exhibited significantly higher sensitivity and specificity as an index of high predictiveness values. Measurement of plasma levels of vitamin D status and chloride co-transporters (KCC2, NKCC1) in children with ASD may help to better understand how sleep disturbances and epilepsy as comorbidities of ASD linked to vitamin D deficiency and peculiar inhibitory/excitatory effects of GABA.
Full article

Figure 1

Figure 1
Open AccessArticle
Are Self-Reported Sensations During tACS Linked to Cortical Excitability Measured by Transcranial Magnetic Stimulation? A Pilot Study in an Older Adult Sample
by
Andrea Seiler, Jimin Park and Flavio Frohlich
Clin. Transl. Neurosci. 2025, 9(2), 20; https://doi.org/10.3390/ctn9020020 - 1 Apr 2025
Abstract
►▼
Show Figures
Stimulation-induced sensations including the perception of flickering lights (phosphenes) and scalp tingling are commonly reported in studies on transcranial alternating current stimulation (tACS). So far, these sensations have been considered benign side-effects of stimulation that may interfere with the blinding of participants in
[...] Read more.
Stimulation-induced sensations including the perception of flickering lights (phosphenes) and scalp tingling are commonly reported in studies on transcranial alternating current stimulation (tACS). So far, these sensations have been considered benign side-effects of stimulation that may interfere with the blinding of participants in trials. It remains unknown what shapes the susceptibility to such side-effects. We hypothesized that cortical excitability predicts their intensity. Hence, we investigated the relationship between sensations during tACS and the motor threshold measured by transcranial magnetic stimulation (TMS). Nine healthy participants aged 50 and older underwent two tACS sessions at 21 Hz and 40 Hz as part of a cross-over pilot study. The stimulation amplitude was individualized to tolerability. Sensations were assessed post-session to calculate correlation with TMS-determined motor thresholds. Stimulation sensations (a flickering light and tingling scalp sensation) correlated with brain excitability as determined by the TMS motor threshold (r = −0.51, p = 0.03, N = 9). The findings suggest a relationship between the intensity of tACS-induced sensations and cortical excitability. Tailoring tACS intensity to individual tolerability and excitability thresholds may enhance the efficacy of tACS by ensuring a more consistent and effective dose relative to endogenous cortical excitability.
Full article

Figure 1
Open AccessReview
Multiple Sclerosis: A Comprehensive Spectrum of Symptoms Beyond Motor Dysfunction
by
Majed Alluqmani
Clin. Transl. Neurosci. 2025, 9(1), 19; https://doi.org/10.3390/ctn9010019 - 17 Mar 2025
Abstract
Multiple sclerosis (MS) is a chronic autoimmune-mediated neurodegenerative disease that affects young adults. The diagnosis of MS currently based on the McDonald criteria, which based on four core principles: the presence of a symptomatic demyelinating syndrome, an objective neurologic finding, the dissemination in
[...] Read more.
Multiple sclerosis (MS) is a chronic autoimmune-mediated neurodegenerative disease that affects young adults. The diagnosis of MS currently based on the McDonald criteria, which based on four core principles: the presence of a symptomatic demyelinating syndrome, an objective neurologic finding, the dissemination in space (DIS), and the dissemination in time (DIT). In addition, the diagnosis of MS relies on the exclusion of any alternative diagnosis. This may implicate the absence of systemic non-neurological symptoms and signs, such as rheumatological, cutaneous, or ophthalmological findings. Nevertheless, the non-neurological symptoms are commonly observed in patients with MS either at the onset of MS, which therefore can delay the diagnosis and the incrementation of a disease-modifying therapy, or during the course of the disease progression. The purpose of our review is to highlight non-neurological symptoms of MS that frequently go undiagnosed or mistakenly linked to other conditions, aiming for the more accurate and earlier diagnosis of MS.
Full article
(This article belongs to the Section Neuroscience/translational neurology)
Open AccessPerspective
The Interdisciplinary Synergy Between Neurology and Psychiatry: Advancing Brain Health
by
Alice Accorroni, Umberto Nencha and Indrit Bègue
Clin. Transl. Neurosci. 2025, 9(1), 18; https://doi.org/10.3390/ctn9010018 - 15 Mar 2025
Cited by 1
Abstract
The study of brain disorders has long been central to both neurology and psychiatry, with these two disciplines evolving as distinct yet deeply interconnected fields. In fact, these specialties often share overlapping symptoms, neural pathways, and treatment modalities, making interdisciplinary collaboration essential. Despite
[...] Read more.
The study of brain disorders has long been central to both neurology and psychiatry, with these two disciplines evolving as distinct yet deeply interconnected fields. In fact, these specialties often share overlapping symptoms, neural pathways, and treatment modalities, making interdisciplinary collaboration essential. Despite this, such collaborations remain sparse, particularly in clinical settings, research, training, and policy development. The increasing global burden of brain disorders has induced a paradigm shift, emphasizing the need for cooperative efforts to preserve brain health. Effective interdisciplinary collaborations between neurology and psychiatry as well as with other partners involved in brain health and other medical specialties is crucial to improving patient outcomes and societal well-being. Furthermore, the development of comprehensive training programs in brain health is vital, aligning with the recent rise in brain medicine as a unified field. This article reviews the historical evolution of neurology and psychiatry, explores current synergies, and identifies areas for future collaboration, particularly in enhancing research, education, and shared preventative strategies. Ultimately, fostering interdisciplinary collaboration between neurology and psychiatry along with other medical specialties and relevant partners will be key to advancing brain health and addressing the global burden of brain disorders.
Full article
(This article belongs to the Special Issue Brain Health)
Open AccessReview
Clot Composition and Pre-Interventional Radiological Characterization for Better Prognosis and Potential Choice of Treatment in Acute Ischemic Strokes
by
Samuel Tell Gurary, Daniela LaGrange, Daniele Botta, Paolo Machi, Isabel Wanke, Felix Tobias Kurz and Karl-Olof Lovblad
Clin. Transl. Neurosci. 2025, 9(1), 17; https://doi.org/10.3390/ctn9010017 - 10 Mar 2025
Abstract
Acute ischemic stroke (AIS) remains a critical concern in clinical practice, with significant implications for patient outcomes and healthcare costs. This review highlights the role of clot composition in AIS, emphasizing the clinical relevance of radiological characterization. Variations in thrombus composition, such as
[...] Read more.
Acute ischemic stroke (AIS) remains a critical concern in clinical practice, with significant implications for patient outcomes and healthcare costs. This review highlights the role of clot composition in AIS, emphasizing the clinical relevance of radiological characterization. Variations in thrombus composition, such as red blood cell (RBC)-rich and white blood cell (WBC)-dominant clots, influence the success of thrombolytic therapies and mechanical thrombectomy. Advanced radiological techniques, including non-contrast CT, CT angiography, and MRI, are essential for pre-interventional clot characterization, guiding optimal treatment decisions. Integrating artificial intelligence (AI) in radiology can enhance the precision of clot composition assessment, facilitating personalized treatment approaches and improving predictive accuracy. By combining histopathological insights with imaging and AI technologies, this review underscores the importance of comprehensive radiological evaluation in the management of AIS, ultimately aiming to enhance clinical outcomes and reduce the burden on healthcare systems.
Full article
(This article belongs to the Section Neuroradiology)
Open AccessReview
Headache and Facial Pain in Multiple Sclerosis: A Narrative Review
by
Lukasz Kolakowski, Katarina Alexandra Ebner and Athina Papadopoulou
Clin. Transl. Neurosci. 2025, 9(1), 16; https://doi.org/10.3390/ctn9010016 - 6 Mar 2025
Abstract
Headache and facial pain syndromes are frequently observed in people with multiple sclerosis (MS), often affecting young adults during pivotal stages of their lives. These conditions can disrupt their ability to work, maintain relationships, and engage in daily activities, leading to significant socio-economic
[...] Read more.
Headache and facial pain syndromes are frequently observed in people with multiple sclerosis (MS), often affecting young adults during pivotal stages of their lives. These conditions can disrupt their ability to work, maintain relationships, and engage in daily activities, leading to significant socio-economic and personal challenges. This narrative review summarizes key epidemiological data and diagnostic insights into headache and facial pain disorders in people with MS. It addresses the complexities of diagnosing these overlapping conditions and highlights specific therapeutic considerations.
Full article
(This article belongs to the Special Issue Brain Health)
►▼
Show Figures

Figure 1
Open AccessArticle
Objective Sleep–Wake Findings in Patients with Post-COVID-19 Syndrome, Fatigue and Excessive Daytime Sleepiness
by
Livia G. Fregolente, Lara Diem, Jan D. Warncke, Julia van der Meer, Anina Schwarzwald, Carolin Schäfer, Helly Hammer, Andrew Chan, Robert Hoepner and Claudio L. A. Bassetti
Clin. Transl. Neurosci. 2025, 9(1), 15; https://doi.org/10.3390/ctn9010015 - 5 Mar 2025
Abstract
Sleep–wake disturbances are common in post-COVID-19 syndrome but lack extensive objective characterization. This study evaluated sleep–wake patterns in 31 patients with post-COVID-19 syndrome referred for fatigue and excessive daytime sleepiness (EDS). Assessments included questionnaires (the fatigue severity scale, the Epworth sleepiness scale, and
[...] Read more.
Sleep–wake disturbances are common in post-COVID-19 syndrome but lack extensive objective characterization. This study evaluated sleep–wake patterns in 31 patients with post-COVID-19 syndrome referred for fatigue and excessive daytime sleepiness (EDS). Assessments included questionnaires (the fatigue severity scale, the Epworth sleepiness scale, and the Beck Depression Index-II), video polysomnography (V-PSG), the multiple sleep latency test (MSLT, n = 15), and actigraphy (n = 29). Patients (70% female, mean age 45 years) had mostly mild acute SARS-CoV-2 infections and were assessed a median of 31 weeks post-infection. Fatigue (fatigue severity scale, median 6.33), sleepiness (the Epworth sleepiness scale, median 15), and depression (Beck depression inventory-II, median 20) scores were elevated. V-PSG showed moderate sleep apnea in 35.5%, increased arousal index in 77.4%, and median sleep stage percentages of NREM1 (12%), NREM2 (37%), NREM3 (19%), and REM (15.8%). MSLT revealed only 13.3% with sleep latencies under 8 min and no sleep-onset REM periods. Actigraphy indicated increased inactivity index in 96.6%, with high variability in time in bed. These findings highlight a polysomnographic and actigraphic profile of increased arousal and clinophilia, alongside moderate sleep apnea and limited objective sleepiness on MSLT. Addressing these multifactorial sleep disturbances is crucial in managing post-COVID-19 syndrome.
Full article
(This article belongs to the Section Clinical Neurophysiology)
►▼
Show Figures

Figure 1
Open AccessReview
Neuromodulation for the Treatment of Refractory Chronic Renal Pain: Clinical Report and Literature Review
by
Gabriel Urreola, Omar Ortuno and Jose Castillo
Clin. Transl. Neurosci. 2025, 9(1), 14; https://doi.org/10.3390/ctn9010014 - 4 Mar 2025
Abstract
Background: Chronic renal pain secondary to urological pathology can severely affect a patient’s quality of life. Utero Pelvic Junction Obstruction (UPJO) and Loin Pain Hematuria Syndrome (LPHS) are two conditions known to cause chronic renal pain that can be refractory to conventional treatments.
[...] Read more.
Background: Chronic renal pain secondary to urological pathology can severely affect a patient’s quality of life. Utero Pelvic Junction Obstruction (UPJO) and Loin Pain Hematuria Syndrome (LPHS) are two conditions known to cause chronic renal pain that can be refractory to conventional treatments. Recent publications demonstrate neuromodulation as an effective treatment option for refractory renal pain. The purpose of this review is to (1) provide evidence from a patient case demonstrating the expanding clinical application of spinal cord stimulation (SCS) for refractory renal pain; (2) provide a review of the literature surrounding UPJO/LPHS and SCS; and (3) express a call to action to investigate the clinical applications of neuromodulation and SCS to treatment-resistant genitourinary pathologies. Methods: We performed a search across PubMed and Web of Science databases to search for patients with UPJO/LPHS who had chronic renal/flank pain and were treated with SCS. Results: In our review, we included five case reports/series (including our own) of eight patients who had chronic flank pain secondary to the genitourinary pathologies UPJO and LPHS. Some patients have been having renal pain for up to 20 years, with all patients experiencing significant or complete alleviation of pain after SCS despite multiple failed attempts with other modalities. Five patients had complete resolution of pain and four patients were able to discontinue their pain medications entirely. Conclusions: SCS is gaining traction in its versatility in the management of various chronic pathologies beyond just CNS conditions. Specifically, UPJO and LPHS are examples of urogenital conditions that may benefit from using SCS. Our case shows an exciting opportunity for managing clinical symptoms in patients who have these conditions but have not undergone surgery for many reasons. Our review and clinical report suggest more research is needed in the application of SCS to genitourinary conditions and those experiencing refractory chronic pain.
Full article
Open AccessPerspective
Perceptual Uncertainty and Its Monitoring in Visual Snow Syndrome: A Multimodal Framework
by
Sophie De Beukelaer, Antonia Klein and Christoph J. Schankin
Clin. Transl. Neurosci. 2025, 9(1), 13; https://doi.org/10.3390/ctn9010013 - 1 Mar 2025
Abstract
Neurobehavioral signatures, such as cortical hyperexcitability, thalamo-cortical dysrhythmia, and pulvinar dysfunction, appear to drive the persistent visual misperceptions in Visual Snow Syndrome (VSS). We propose that heightened perceptual uncertainty and impaired metacognitive monitoring perpetuate these disturbances and formalize these processes within different frameworks
[...] Read more.
Neurobehavioral signatures, such as cortical hyperexcitability, thalamo-cortical dysrhythmia, and pulvinar dysfunction, appear to drive the persistent visual misperceptions in Visual Snow Syndrome (VSS). We propose that heightened perceptual uncertainty and impaired metacognitive monitoring perpetuate these disturbances and formalize these processes within different frameworks (predictive coding, signal detection theory, and attentional control). By clarifying these mechanisms, we aim to inform targeted interventions that could address this currently untreatable condition.
Full article
(This article belongs to the Section Headache)
►▼
Show Figures

Figure 1
Open AccessReview
Migraine-Friendly Workspace: A Swiss Brain Health Initiative
by
Andreas R. Gantenbein, Susanne Wegener, Christoph J. Schankin and Andreas K. Kleinschmidt
Clin. Transl. Neurosci. 2025, 9(1), 12; https://doi.org/10.3390/ctn9010012 - 27 Feb 2025
Abstract
Migraine affects around one billion individuals worldwide, many in their working life, leading to significant personal and societal burdens. As modern working environments continue to change, so do the expectations of new generations of employees. The importance of creating migraine-friendly workspaces is becoming
[...] Read more.
Migraine affects around one billion individuals worldwide, many in their working life, leading to significant personal and societal burdens. As modern working environments continue to change, so do the expectations of new generations of employees. The importance of creating migraine-friendly workspaces is becoming increasingly pressing. The Swiss Headache Society’s migraine-friendly workspace (MFWS) proposal aims to reduce direct and indirect costs associated with migraines in the workspace and provides practical recommendations and interventions for designing environments that promote employee well-being and productivity.
Full article
(This article belongs to the Section Headache)
►▼
Show Figures

Figure 1
Open AccessCase Report
The Physiatrist in Intensive Care: Role, Tasks, and Critical Issues in a Clinical Case Report Analysis
by
Valerio Massimo Magro, Andrea Sorbino, Nicola Manocchio, Concetta Ljoka and Calogero Foti
Clin. Transl. Neurosci. 2025, 9(1), 11; https://doi.org/10.3390/ctn9010011 - 26 Feb 2025
Cited by 3
Abstract
►▼
Show Figures
Background: Disorders of Consciousness (DoC) following acute brain injuries, such as intracerebral hemorrhage, present significant clinical challenges in intensive care and rehabilitation settings. Early multidisciplinary interventions, including physiatric care, are critical in optimizing recovery trajectories. However, evidence regarding the timing and intensity of
[...] Read more.
Background: Disorders of Consciousness (DoC) following acute brain injuries, such as intracerebral hemorrhage, present significant clinical challenges in intensive care and rehabilitation settings. Early multidisciplinary interventions, including physiatric care, are critical in optimizing recovery trajectories. However, evidence regarding the timing and intensity of rehabilitation interventions remains limited. This case report highlights the role of physiatrists in managing a critically ill patient with a DoC in an Intensive Care Unit (ICU), focusing on early rehabilitation strategies and individualized care planning. Case presentation: A 63-year-old male with a history of hypertension and cardiac disease presented with a left hemispheric hemorrhage and quadriventricular intraventricular hemorrhage. The patient was admitted to the ICU in a comatose state (Glasgow Coma Scale [GCS] 5). Initial physiatric evaluation revealed a critical condition precluding immediate initiation of an Individual Rehabilitation Project (IRP). Over subsequent weeks, clinical improvements were observed, including an increased GCS and Coma Recovery Scale-Revised (CRS-R) score. A tailored IRP was implemented, emphasizing passive mobilization to prevent complications such as muscle atrophy, joint contractures, and pressure ulcers. The patient demonstrated gradual progress, transitioning to a Minimally Conscious State (MCS) and achieving improved joint mobility and reduced peripheral edema. Discussion and Conclusions: This case underscores the pivotal role of physiatrists in ICU settings, particularly for patients with DoC. Early physiatric interventions, even in critically ill patients, can prevent secondary complications and facilitate functional recovery. Close collaboration with ICU teams and infectious disease specialists ensured the safe implementation of rehabilitation strategies despite the patient’s severe condition. The observed clinical improvements highlight the potential benefits of early mobilization and individualized care plans, both in terms of survival (quoad vitam) and quality of life (quoad valetudinem). This report emphasizes the need for further research to refine rehabilitation practices for patients with DoC, bridging gaps between acute care and neurorehabilitation.
Full article

Figure 1

Figure 1
Open AccessBrief Report
The Central Vein Sign as a Radiologic Tool to Predict the Diagnosis of Radiation Necrosis in Intracranial Metastatic Cancer Patients
by
Joseph P. Antonios, Nana Adenu-Mensah, Brianna C. Theriault, Miguel Millares-Chavez, Anita Huttner, Mariam Aboian and Veronica L. Chiang
Clin. Transl. Neurosci. 2025, 9(1), 10; https://doi.org/10.3390/ctn9010010 - 21 Feb 2025
Abstract
Radiosurgery (SRS) is a primary treatment for intracranial metastatic disease, but it can lead to cerebral radiation necrosis (RN) in approximately 25% of cases. Unlike tumor progression (TP), which indicates a lack of response to treatment, RN suggests an effective SRS response. Differentiating
[...] Read more.
Radiosurgery (SRS) is a primary treatment for intracranial metastatic disease, but it can lead to cerebral radiation necrosis (RN) in approximately 25% of cases. Unlike tumor progression (TP), which indicates a lack of response to treatment, RN suggests an effective SRS response. Differentiating RN from TP is challenging using standard radiological imaging, often necessitating surgical biopsy. This study investigates the utility of the central vein sign (CVS), a novel MRI biomarker associated with immune infiltrate-rich perivascular spaces, to differentiate RN from TP. Overall, our findings suggest that pre-SRS CVS could serve as a non-invasive marker to distinguish RN from TP, aiding in treatment decisions. Further research is needed to validate CVS as a predictive marker in larger patient cohorts and explore its potential in guiding cancer therapy response.
Full article
(This article belongs to the Section Neuroradiology)
►▼
Show Figures

Figure 1

Figure 1
Highly Accessed Articles
Latest Books
E-Mail Alert
News
Topics
Topic in
Brain Sciences, CTN, Neurology International, NeuroSci
Neurological Updates in Neurocritical Care
Topic Editors: Gabriele Melegari, Elisabetta BertelliniDeadline: 28 February 2026

Conferences
Special Issues
Special Issue in
CTN
Brain Health
Guest Editors: Lukas Sveikata, Susanne Wegener, Indrit BègueDeadline: 30 June 2025